SavedAdd your journal

Journals / The Journal of Pediatric Research / 2018 / Cilt: 5 - Sayı: 3

A Novel De Novo Missense Mutation in HNF4A Resulting in Sulfonylurea-Responsive Maturityonset Diabetes of the Young

Sezer ACAR
AYHAN ABACI
KORCAN DEMİR
Taha Reşid ÖZDEMİR
Berk OZYILMAZ
Pages
156–160
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion,genetic testing should be considered in order to establish an accurate diagnosis and provide an opinion in determining the appropriate type oftreatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes, with autosomal-dominant inheritance, which usually develops before25 years of age.
📊
Key Findings & Data:Heterozygousinactivating hepatocyte nuclear factor 4A (HNF4A) mutations, one of the rare subtypes of MODY, cause impaired insulin secretion and subsequentglucose intolerance especially in adolescence.
💡
Conclusion & Impact:In conclusion,genetic testing should be considered in order to establish an accurate diagnosis and provide an opinion in determining the appropriate type oftreatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes, with autosomal-dominant inheritance, which usually develops before25 years of age. MODY is classically caused by a heterozygous mutation of genes known to affect insulin production or secretion. Heterozygousinactivating hepatocyte nuclear factor 4A (HNF4A) mutations, one of the rare subtypes of MODY, cause impaired insulin secretion and subsequentglucose intolerance especially in adolescence. Conversely, HNF4A mutations are also known to be associated with macrosomia and hyperinsulinemichypoglycemia in newborns. Herein, we report a rare cause of diabetes resulting from a novel heterozygous mutation in the HNF4A gene. In conclusion,genetic testing should be considered in order to establish an accurate diagnosis and provide an opinion in determining the appropriate type oftreatment.

🔖

Cite This Article

ACAR, S., ABACI, A., DEMİR, K., ÖZDEMİR, T. R., OZYILMAZ, B. (2018). A Novel De Novo Missense Mutation in HNF4A Resulting in Sulfonylurea-Responsive Maturityonset Diabetes of the Young. The Journal of Pediatric Research, Cilt: 5 - Sayı: 3, 156–160. https://ajindex.com/articles/362808

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Chambers C, Fouts A, Dong F, et al. Characteristics of maturity onset diabetes of the young in a large diabetes center. Pediatr Diabetes 2016;17:360-7.
  2. Shepherd M, Ellis I, Ahmad AM, et al. Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabet Med 2001;18:417-21.
  3. Ellard S, Bellanné-Chantelot C, Hattersley AT; European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008;51:546-53.
  4. Stanik J, Dusatkova P, Cinek O, et al. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed. Diabetologia 2014;57:480-4.
  5. Pearson ER, Boj SF, Steele AM, et al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 2007;4:e118. Roženková K, Güemes M, Shah P, Hussain K. The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia. J Clin Res Pediatr Endocrinol 2015;7:86-97.
  6. Pearson ER, Pruhova S, Tack CJ, et al. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia 2005;48:878-85.
  7. Flanagan SE, Kapoor RR, Mali G, et al. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol 2010;162:987-92.
  8. Anık A, Çatlı G, Abacı A, et al. Molecular diagnosis of maturityonset diabetes of the young (MODY) in Turkish children by using targeted next-generation sequencing. J Pediatr Endocrinol Metab 2015;28:1265-71.
  9. Ağladıoğlu SY, Aycan Z, Çetinkaya S, et al. Maturity onset diabetes of youth (MODY) in Turkish children: sequence analysis of 11 causative genes by next generation sequencing. J Pediatr Endocrinol Metab 2016;29:487-96.
  10. Haliloglu B, Hysenaj G, Atay Z, et al. GCK gene mutations are a common cause of childhood-onset MODY (maturityonset diabetes of the young) in Turkey. Clin Endocrinol (Oxf) 2016;85:393-9.
  11. Thanabalasingham G, Pal A, Selwood MP, et al. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young. Diabetes Care 2012;35:1206-12.
  12. Chauhan SP, Grobman WA, Gherman RA, et al. Suspicion and treatment of the macrosomic fetus: a review. Am J Obs Gynecol 2005;193:332-46.
  13. Rubio-Cabezas O, Hattersley AT, Njølstad PR, et al. ISPAD Clinical Practice Consensus Guidelines 2014. The diagn